Metrics
Publication
123
Open Access
5
UN Sustainable Development Goals
Education
1987 - 1994
1987 - 1994Post Doctorate of Medicine
Istanbul University, Istanbul Medical Faculty, Dahili Tıp/İç Hastalıkları/Hematoloji Bilim Dalıi, Turkey
1980 - 1984
1980 - 1984Expertise In Medicine
Istanbul University, Istanbul Medical Faculty, İç Hastalıkları, Turkey
Dissertations
2016
2016Expertise In Medicine
Yeni Tanı Lenfoproliferatif Hastalık Nedeni ile Yüksek Doz Kortikosteroid Tedavisi Başlanan 50 Yaş ve Üzeri Hastalarda Osteoporoz Sıklığı ve Kemik Fraktür Rsikinin Belirlenmesi
Istanbul University, İc Hastalıkları Anabilim Dalı, Hematoloji Bilim Dalı
Research Areas
Medicine
Health Sciences
Internal Medicine Sciences
Internal Diseases
Hematology
Academic Positions
1999 - Present
1999 - PresentProfessor
Istanbul University, Istanbul Medical Faculty, Dahili Tıpi Bilimlerii
Non Academic Experience
1984 - 1987
1984 - 1987İç hastalıkları uzmanı
SSK Tavşanlı Hastanesi, İç hastalıkları uzmanı
Articles
All (67)
SCI-E, SSCI, AHCI (42)
SCI-E, SSCI, AHCI, ESCI (55)
ESCI (13)
Scopus (50)
TRDizin (20)
Other Publications (5)
2025
20251. Impact of COVID-19 on Hematologic Disorders: Clinical Insights and Challenges
ERDEM S., SERT EKİNCİ S., ÖZBALAK M. M., MASTANZADE M., YÖNAL HİNDİLERDEN İ., YENEREL M. N., et al.
Istanbul Medical Journal , vol.26, 2025 (ESCI)
2024
20242. Analysis of cerebrospinal fluid chimerism after hematopoietic stem cell transplantation: Case report
Ogret Y., Tiryaki T. O., Cinar C. K., Hindilerden I. Y., Ozluk D. O., Nalcaci M., et al.
Hematology, Transfusion and Cell Therapy
, vol.46, 2024 (ESCI)
2024
20243. Akut Miyeloid Lösemi’li Olgularda inv(3)/t(3;3) ile 7.Kromozomun Anomalilerinin Prognoza Etkisi
BAYRAK TOKAÇ A. G., BAĞATIR G., ERDEM S., ÇEFLE K., ÖZTÜRK Ş., YENEREL M. N., et al.
Manisa Celal Bayar Üniversitesi Eğitim Fakültesi Dergisi
, vol.11, pp.334-339, 2024 (Peer-Reviewed Journal)
2024
20244. Long-Term Remission After Nelarabine and Donor Lymphocyte Infusion in a Patient With T-ALL Who Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation
Koruk K., Tiryaki T. O., ÖZBALAK M. M., MASTANZADE M., Arslan O., BEŞIŞIK S., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, 2024 (SCI-Expanded)
2024
20245. Immunosuppression-Based Lymphoproliferative Disease Features and Parameters Affecting Survival
Göktaş Aydın S., Nalçacı M., Yönal Hindilerden İ., Beşışık S., Yenerel M. N.
Genel Tıp Dergisi , vol.34, no.5, pp.671-679, 2024 (Peer-Reviewed Journal)
2024
20246. Raman Spectroscopy of Blood Serum for Essential Thrombocythemia Diagnosis: Correlation with Genetic Mutations and Optimization of Laser Wavelengths
Aday A., Bayrak A. G., Toraman S., Hindilerden İ. Y., Nalçacı M., Depciuch J., et al.
CELL BIOCHEMISTRY AND BIOPHYSICS
, vol.82, no.3, pp.2989-2999, 2024 (SCI-Expanded)
2024
20247. INFECTION EVENTS IN MULTIPLE MYELOMA DURING THE EARLY PERIOD OF AUTOLOGOUS STEM CELL TRANSPLANTATION
AMIKISHIYEV S., BEŞIŞIK S., YÖNAL HİNDİLERDEN İ., YENEREL M. N., ÇAĞATAY A. A., ERDEM S., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
, vol.87, no.3, pp.246-252, 2024 (ESCI)
2024
20248. Analysis of cerebrospinal fluid chimerism after hematopoietic stem cell transplantation: Case report.
Ögret Y., Tiryaki T. O., Çınar Ç., Yönal Hindilerden İ., Özlük D. Ö., Nalçacı M., et al.
Hematology, Transfusion and Cell Therapy , vol.46, no.6, pp.1-2, 2024 (Scopus)
2023
20239. Comparison of different plerixafor-based strategies for adequate hematopoietic stem cell collection in poor mobilizers
Sadri S., Yonal-Hindilerden I., mutlu Y. g., tiryaki t. o., Gemici A., Beköz H. S., et al.
The European Research Journal
, vol.9, no.6, pp.1368-1379, 2023 (Peer-Reviewed Journal)
2023
202310. The Effect of T-Lymphocyte Subgroups at Diagnosis on the Prognosis of Chronic Lymphocytic Leukemia (CLL)
Seyithanoglu D., Nazligul E., ÖZBALAK M. M., MASTANZADE M., ERDEM S., NALÇACI M., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, 2023 (SCI-Expanded)
2023
202311. Impact of Epitope Match on Stem Cell Transplantation
ÖGRET Y., TİRYAKİ T. O., Zanjani B. N., İZGİ D., Cinar C. K., Hindilerden I. Y., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, 2023 (SCI-Expanded)
2023
202312. FTIR- based serum structure analysis in molecular diagnostics of essential thrombocythemia disease
Guleken Z., Ceylan Z., Aday A., Bayrak A. G., Hindilerden İ. Y., Nalçacı M., et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
, vol.245, 2023 (SCI-Expanded)
2023
202313. Comparison of eGFR formulas (CKD-EPI and MDRD) in patients with multiple myeloma
Erinc O., yeşilyurt s., Nalcaci M.
Cukurova Medical Journal
, vol.48, no.2, pp.336-343, 2023 (ESCI)
2023
202314. Factors Associated with Hepatitis B Virus Reactivation and Vaccination Success in Patients Receiving Chemotherapy for Multiple Myeloma and Lymphoma
KUL A. N., ERKEK E., NALÇACI M.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları
, vol.7, no.1, pp.20-28, 2023 (Peer-Reviewed Journal)
2023
202315. Prognostic and Predictive Value of Baseline Hypogammaglobulinemia for Chronic Lymphocytic Leukemia Prognosis and Complications
Kuş F., Bektaş M., Şenkal N., Çatma Y., Atalah F., Akyıldız A., et al.
Eurasian Journal of Medical Advances
, no.3, pp.33-39, 2023 (Peer-Reviewed Journal)
2022
202216. Correlation of tissue chimerism with peripheral blood in early-stage allogeneic stem cell transplant patients
Ogret Y., Ozbalak E. P., Hindilerden I. Y., Besisik S. K., Nalcaci M., Oguz F. S.
HLA
, vol.99, no.5, pp.491-492, 2022 (SCI-Expanded)
2022
202217. Circulating Endothelial Progenitor Cells and Their Relation to Thrombosis in Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia
Erkek E. T., Nazligul E., Nalcaci M., Yenerel M. N.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
, vol.38, no.2, pp.319-326, 2022 (SCI-Expanded)
2022
202218. The association of CMV infection with bacterial and fungal infections in hematopoietic stem cell transplant recipients: a retrospective single-center study.
Öksüz L., Hi Ndi Lerden İ. Y., Erci Yestepe M., Önel M., Hi Ndi Lerden F., Çağatay A., et al.
The new microbiologica
, vol.45, no.1, pp.40-50, 2022 (SCI-Expanded)
2022
202219. ERAP1 Gen İfadesinin Plazma Hücre Diskrazilerinde İncelenmesi
Sariman M., KARAÇAM B., Ayer M., SIRMA EKMEKCİ S., SUER İ., ÇEFLE K., et al.
İstanbul Kanuni Sultan Süleyman Tıp Dergisi
, vol.14, no.2, pp.120-124, 2022 (Peer-Reviewed Journal)
2022
202220. Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients
Ulu B. U., Dal M. S., Hindilerden I. Y., Akay O. M., MEHTAP Ö., Buyukkurt N., et al.
JOURNAL OF CHEMOTHERAPY
, vol.34, no.3, pp.190-198, 2022 (SCI-Expanded)
2021
202121. Assessment of Left Ventricular Function using a Two-Dimensional Speckle Tracking Echocardiography in Asymptomatic Survivors of Hodgkin's Lymphoma in Long-Term Follow-Up
Altinkaynak M., Ozer P., Atici A., Basar R., Oztop N., Umman B., et al.
ISTANBUL MEDICAL JOURNAL
, vol.22, no.4, pp.300-305, 2021 (ESCI)
2021
202122. Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study
Ozbalak M. M., Akay O. M., PEHLİVAN M., Yildiz B., UZAY A., Yigenoglu T. N., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, vol.21, 2021 (SCI-Expanded)
2021
202123. R-CHOP Chemotherapy with a Rituximab Biosimilar (Redditux®) for Patients with de novo Diffuse Large B-cell Lymphoma: First Preliminary Results of a Real-Life Single-Center Experience from Turkey
Özbalak M. M., Mastanzade M., Özlük Ö., Tiryaki T. O., Pınar Özbalak E., Yönal Hindilerden İ., et al.
İstanbul Kanuni Sultan Süleyman Tıp Dergisi , vol.13, no.3, pp.194-198, 2021 (Peer-Reviewed Journal)
2021
202124. Non-disease-originated leukocyte subset chimerism and the clinical outcome in hematopoetic stem cell transplantation
Mastanzade M., BEŞIŞIK S., ÖGRET Y., OĞUZ F., Hindilerden I. Y., NALÇACI M.
EUROPEAN JOURNAL OF IMMUNOLOGY
, pp.367, 2021 (SCI-Expanded)
2021
202125. Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma
Yonal-Hindilerden I., Hindilerden F., Mastanzade M., Tiryaki T. O., Tasan-Yenigun S., BİLEN Y., et al.
FRONTIERS IN ONCOLOGY
, vol.11, 2021 (SCI-Expanded)
2020
202026. The Clinical Significance of JAK2V617F Mutational Status on Phenotypic Features in Philadelphia-Negative Chronic Myeloproliferative Neoplasms
Sahin E., Yonal-Hindilerden I., Hindilerden F., Daglar-Aday A., Nalcaci M.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, vol.20, 2020 (SCI-Expanded)
2020
202027. The Clinical Impact of the Burden of JAK2V617F Mutated Allele in Philadelphia-Negative Chronic Myeloproliferative Neoplasms
Yonal-Hindilerden I., Sahin E., Hindilerden F., Daglar-Aday A., Nalcaci M.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, vol.20, 2020 (SCI-Expanded)
2020
202028. A Case with Hepatic Involvement Mimicking Metastatic Disease in Multiple Myeloma
Erciyestepe M., Tiryaki T. O., Hindilerden I. Y., Yegen G., Nalcaci M.
CASE REPORTS IN HEMATOLOGY
, vol.2020, 2020 (ESCI)
2020
202029. Retrospective Analysis of Peripheral T-Cell Lymphoma Patients: Single Center 'Real-Life' Experience
Ozbalak M. M., MASTANZADE M., Ozluk O., TİRYAKİ T. O., Hindilerden I. Y., YENEREL M. N., et al.
MEDICAL JOURNAL OF BAKIRKOY
, vol.16, no.4, pp.392-398, 2020 (ESCI)
2020
202030. Budd-Chiari Syndrome: An Unusual Complication of AL Amyloidosis
TİRYAKİ T. O., Hindilerden I. Y., YEGEN G., NALÇACI M.
TURKISH JOURNAL OF HEMATOLOGY
, vol.37, no.2, pp.130-131, 2020 (SCI-Expanded)
2019
201931. Clostridium difficile Infection after Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Study
Hindilerden I. Y., Erciyestepe M., Nalcaci M., Kalayoglu-Besisik S., Sargin D., Aktan M.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, vol.19, 2019 (SCI-Expanded)
2019
201932. The Clinical Significance of JAK2V617F Mutation for Philadelphia-Negative Chronic Myeloproliferative Neoplasms in Patients with Splanchic Vein Thrombosis
Hindilerden F., Hindilerden I. Y., Pinarbasi B., HANÇER V. S., Kaymakoglu S., Kucukkaya R. D., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, vol.19, 2019 (SCI-Expanded)
2018
201833. Detection of bone marrow involvement with FDG PET/CT in patients with newly diagnosed lymphoma
Ozpolat H. T., Yilmaz E., Goksoy H. S., Ozpolat S., Dogan O., Unal S. N., et al.
BLOOD RESEARCH
, vol.53, no.4, pp.281-287, 2018 (ESCI)
2018
201834. A misleading presentation of T cell/histiocyte rich B-cell lymphoma mimicking osteomyelitis
Ozpolat T., Saka B., Yonal-Hindilerden I., Tascioglu C., Dogan O., Nalcaci M.
BLOOD RESEARCH
, vol.53, no.3, pp.250-251, 2018 (ESCI)
2018
201835. Esansiyel Trombositemi ve Primer Miyelofibrozis Hastalarımızın Klinik ve Laboratuvar Bulgularının Karşılaştırılması
YONAL-HINDILERDEN İ., HINDILERDEN F., DAĞLAR ADAY A., YILMAZ C., YAVUZ A. S., NALÇACI M., et al.
İç Hastalıkları Dergisi , vol.25, no.1, pp.35-50, 2018 (Peer-Reviewed Journal)
2018
201836. Primary Mediastinal Large B-Cell Lymphoma As an Incidental Finding: Report of a Case
Yonal-Hindilerden I., Hindilerden F., Arslan S., Dogan I. O., Nalcaci M.
TURKISH JOURNAL OF HEMATOLOGY
, vol.35, no.2, pp.141-142, 2018 (SCI-Expanded)
2017
201737. The Effect of Suppressed Levels of Uninvolved Immunoglobulins on the Prognosis of Symptomatic Multiple Myeloma.
Sari M., Sari S., Nalcaci M.
Turkish journal of haematology : official journal of Turkish Society of Haematology
, vol.34, no.2, pp.131-136, 2017 (SCI-Expanded)
2017
201738. Epidermotropic skin involvement of splenic marginal zone B-cell lymphoma: a diagnostic challenge.
Baykal C., Erdem S., Kılıç S., Nalçacı M., Büyükbabanı N.
Journal of cutaneous pathology
, vol.44, no.3, pp.312-314, 2017 (SCI-Expanded)
2017
201739. Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases
Hindilerden F., Yonal-Hindilerden I., Yenerel M. N., Nalcaci M., Diz-Kucukkaya R.
TURKISH JOURNAL OF HEMATOLOGY
, vol.34, no.1, pp.72-80, 2017 (SCI-Expanded)
2016
201640. Comparison of the two most frequent morphological patterns, excluding amyloidosis, of kidney involvement in monoclonal gammopathy
Tepe M. O., Ozluk Y., Sari M., Yazici H., YEGEN G., Nalcaci M., et al.
VIRCHOWS ARCHIV
, vol.469, 2016 (SCI-Expanded)
2016
201641. MALT lymphoma of the left biceps muscle: a rare case with an interesting presentation
Yonal-Hindilerden I., Hindilerden F., Dogan I. O., Nalcaci M.
SPRINGERPLUS
, vol.5, 2016 (SCI-Expanded)
2016
201642. The frequency of C609T polymorphism in the NQO1 gene and its relation to cytogenetic abnormalities in patients with myelodysplastic syndrome.
Bagatır G., Sırma S. Ö., Palanduz S., Ozturk Ş., Cefle K., Ozbek U., et al.
Cellular and molecular biology (Noisy-le-Grand, France)
, vol.62, no.7, pp.61-5, 2016 (SCI-Expanded)
2016
201643. Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis
Yonal I., Daglar-Aday A., Akadam-Teker B., Yilmaz C., Nalcaci M., Yavuz A., et al.
TURKISH JOURNAL OF HEMATOLOGY
, vol.33, no.2, pp.94-101, 2016 (SCI-Expanded)
2016
201644. The Clinical Significance of IDH Mutations in Essential Thrombocythemia and Primary Myelofibrosis.
YONAL-HINDILERDEN I., Daglar-Aday A., HINDILERDEN F., AKADAM-TEKER B., YILMAZ C., NALCACI M., et al.
Journal of clinical medicine research
, vol.8, pp.29-39, 2016 (Peer-Reviewed Journal)
2015
201545. Prognostic significance of asxl1, JAK2V617F mutations and JAK2V617F allele burden in philadelphia-negative myeloproliferative neoplasms
YONAL-HINDILERDEN I., Daglar-Aday A., AKADAM-TEKER B., YILMAZ C., NALÇACI M., Yavuz A. S., et al.
Journal of Blood Medicine
, vol.6, pp.157-175, 2015 (ESCI)
2015
201546. The Burden of JAK2V617F Mutated Allele in Turkish Patients With Myeloproliferative Neoplasms.
YONAL-HINDILERDEN I., Daglar-Aday A., AKADAM-TEKER B., YILMAZ C., NALCACI M., YAVUZ A., et al.
Journal of clinical medicine research
, vol.7, pp.161-70, 2015 (Peer-Reviewed Journal)
2015
201547. Hairy Cell Leukemia Presenting with Isolated Skeletal Involvement Successfully Treated by Radiation Therapy and Cladribine: A Case Report and Review of the Literature
Yonal-Hindilerden I., Hindilerden F., Bulut-Dereli S., Yildiz E., Dogan I. O., Nalcaci M.
CASE REPORTS IN HEMATOLOGY
, 2015 (ESCI)
2014
201448. The Importance of Eculizumab in Patients with Atypical Hemolytic Uremic Syndrome: Single Center Experience
Yenerel M. N., Aktan M., Yildiz A., Caliskan Y., Nalcaci M.
BLOOD
, vol.124, no.21, 2014 (SCI-Expanded)
2013
201349. Rosai-Dorfman disease with diffuse gastrointestinal involvement
Baran B., Karaca C., Soyer O. M., Yonal I., Isiklar A. D., Cakmak R., et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
, vol.25, no.7, pp.869-874, 2013 (SCI-Expanded)
2013
201350. Review of therapeutic options and the management of patients with myelodysplastic syndromes
ÖZCAN M. A., İLHAN O., ÖZCEBE O. İ., Nalcaci M., Gulbas Z.
EXPERT REVIEW OF HEMATOLOGY
, vol.6, no.2, pp.165-189, 2013 (SCI-Expanded)
2013
201351. MPL W515L/K Mutations in Chronic Myeloproliferative Neoplasms.
Akpinar T. S., Hancer V. S., Nalcaci M., Diz-Kucukkaya R.
Turkish journal of haematology : official journal of Turkish Society of Haematology
, vol.30, no.1, pp.8-12, 2013 (SCI-Expanded)
2012
201252. The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis
Yonal I., Pinarbasi B., Hindilerden F., Hancer V. S., Nalcaci M., Kaymakoglu S., et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
, vol.34, no.3, pp.388-396, 2012 (SCI-Expanded)
2012
201253. A case of chronic lymphocytic leukemia with massive ascites
Yonal I., Nazligul E., Tas G., Agan M. R., YENEREL M. N., NALÇACI M.
RARE TUMORS
, vol.4, no.4, pp.165-168, 2012 (ESCI)
2011
201154. Vasculitis in A Patient with Hairy Cell Leukemia
Ozkok A., Elcioglu O. C., Akpinar T. S., Nalcaci M.
INTERNAL MEDICINE
, vol.50, no.21, pp.2713, 2011 (SCI-Expanded)
2009
200955. PRESENTING CLINICAL AND LABORATORY FINDINGS OF 282 PATIENTS WITH HODGKIN'S DISEASE
Sahinoglu S., Yenerel M. N., Guvenc S., Kucukkaya R. D., Nalcaci M.
NOBEL MEDICUS
, vol.5, no.2, pp.18-23, 2009 (SCI-Expanded)
2008
200856. A case applied with decompensated heart failure findings diagnosed as primary effusion lymphoma
Yildirim N. D., Bicakci E., Elverdi T., Yenerel M. N., Kucukkaya R. D., Dogan O., et al.
TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI
, vol.25, no.2, pp.152-155, 2008 (SCI-Expanded)
2008
200857. Primary pulmonary lymphoma: A report of two cases
Yildirim N. D., Elverdi T., Bicakci E., Gokcen G., Yenerel M. N., Kucukkaya R. D., et al.
TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI
, vol.25, no.1, pp.82-86, 2008 (SCI-Expanded)
2008
200858. Atypical M-protein localization in protein electrophoresis in a patient with multiple myeloma
Yildirim N. D., Ayer M., Hatipoglu E., Kucukkaya R. D., Yenerel M. N., Nalcaci M.
TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI
, vol.25, no.1, pp.56-59, 2008 (SCI-Expanded)
2007
200759. Leukocytoclastic vasculitis due to thalidomide in multiple myeloma
Yildirim N. D., Ayer M., Kuecuekkaya R. D., Alpay N., Mete O., Yenerel M. N., et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
, vol.37, no.9, pp.704-707, 2007 (SCI-Expanded)
2007
200760. CLINICAL FOLLOW-UP AND TREATMENT RESPONSE OF THE 162 PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA
YENEREL M. N., Atamer T., Ayer M., Yildirim N. D., Kucukkaya R. D., Yavuz A. S., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
, vol.70, no.1, pp.6-10, 2007 (ESCI)
2005
200561. Genotoxicity and sister chromatid exchange in patients with myelodysplastic disorders.
Oztürk S., PALANDUZ S., CEFLE K., TUTKAN G., UCUR A., DINCOL G., et al.
Cancer genetics and cytogenetics
, vol.159, pp.148-50, 2005 (SCI-Expanded)
2004
200462. Factor XIII Val34Leu polymorphism does not contribute to the prevention of thrombotic complications in patients with antiphospholipid syndrome
DIZ-KUCUKKAYA R., HANCER V. S., Inanc M., NALCACI M., PEKCELEN Y.
LUPUS
, vol.13, no.1, pp.32-35, 2004 (SCI-Expanded)
2002
200263. Myeloid antigen expression provides favorable outcome in patients with adult acute lymphoblastic leukemia: a single-center study
Yeneral M. N., Atamer T., YAVUZ A. F., Kucukkaya R., BEŞIŞIK S., Aktan M., et al.
ANNALS OF HEMATOLOGY
, vol.81, no.9, pp.498-503, 2002 (SCI-Expanded)
2002
200264. SITOZIN ARABINOZID E BAĞLI AKUT SEREBELLAR SENDROM OLGU SUNUMU
BAHAT-ÖZTÜRK G., SOYLUK SELÇUKBİRİCİK Ö., ÖZTÜRK S., YEŞİLOT BARLAS N., NALÇACI M., DİNÇOL G.
İstanbul Tıp Fakültesi Mecmuası , 2002 (Peer-Reviewed Journal)
2002
200265. Coexistence of homozygous factor V Leiden mutation and antiphospholipid antibodies in two patients presented with Budd-Chiari syndrome
Diz-Kucukkaya R., Demir K., Yenerel M. N., Nalcaci M., Kaymakoglu S., Inanc M.
HAEMATOLOGIA
, vol.32, no.1, pp.73-77, 2002 (SCI-Expanded)
2001
200166. Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study
Diz-Kucukkaya R., hacıhanefioğlu a., Yenerel M. N., TURGUT M., Keskin H., Nalcaci M., et al.
BLOOD
, vol.98, no.6, pp.1760-1764, 2001 (SCI-Expanded)
2001
200167. CD15-expressing phagocytic plasma cells in a patient with multiple myeloma
KUCUKKAYA R., HACIHANEFIOGLU A., YENEREL M. N., TURGUT M., NALCACI M., KESKIN H., et al.
BLOOD
, vol.97, no.2, pp.581-583, 2001 (SCI-Expanded)
Papers Presented at Peer-Reviewed Scientific Conferences
2025
20251. HLA Eplet Uyumsuzluğunun Hematopoietik Kök Hücre Nakli Sonrası GVHD, Relaps ve Sağkalım Üzerindeki Etkisi: Çok Boyutlu Klinik ve İstatistiksel Değerlendirme.
Öğret Y., Yönal Hindilerden İ., Nasr B., Tiryaki T. O., Çınar Ç., Kıvanç D., et al.
HİTİD 1. Ulusal HLA İmmünogenetiği ve Transplantasyon İmmünolojisi Kongresi, Antalya, Turkey, 21 - 23 November 2025, pp.12-13, (Summary Text)
2025
20252. Investigation of CD4+, CD8+, and T Follicular Helper Cells in Follicular Lymphoma Patients
Akboğa F., HİNDİLERDEN F., YÖNAL HİNDİLERDEN İ., GÜLTÜRK E., DENİZ G., GELMEZ M. Y., et al.
6th INTERNATIONAL MOLECULAR IMMUNOLOGY & IMMUNOGENETICS CONGRESS (MIMIC-VI), 28 April 2025, (Summary Text)
2024
20243. Akut Miyeloid Lösemide İzositrat Dehidrogenaz 1 (IDH1) Gen Mutasyonu Sıklığı ve Klinik: Tek Merkez Deneyimi
ÇATMA Y., ERDEM S., ADAY A., MASTANZADE M., ÖZBALAK M. M., YÖNAL HİNDİLERDEN İ., et al.
50. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 29 October 2024, pp.228, (Summary Text)
2023
20234. FOLİKÜLER LENFOMALI HASTALARDA FOLİKÜLER SİTOTOKSİK T HÜCRELERİ
Akboğa F., Kuyaş M. İ., Hindilerden F., Yönal Hindilerden İ., Gültürk E., Erbilgin Y., et al.
26. Ulusal İmmünoloji Kongresi, Ankara, Turkey, 11 - 13 November 2023, pp.49, (Summary Text)
2023
20235. Multipl miyelomda kemik iliği fibrozisinin ekstramedüller hastalık ile ilişkisi
Konyaoğlu H., Altay A. Y., Işık E. G., Oluk B., Taghiyeva N., Sakcı E., et al.
25. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 8 - 12 November 2023, pp.77-78, (Full Text)
2023
20236. The effect of epitope mismatches on haploidentical haematopoietic stem cell transplantation
Ögret Y., Yönal Hindilerden İ., Tiryaki T. O., İzgi D., Çınar Ç., Nalçacı M., et al.
Annual EFI region 8 Balkan EPT meeting, Sofija-Grad, Bulgaria, 3 - 05 November 2023, pp.3-4, (Summary Text)
2023
20237. Foliküler Lenfomalı Hastalarda Foliküler Sitotoksik T Hücre Alt Grupları ve Fonksiyonları
Akboğa F., Kuyaş M. İ., HİNDİLERDEN F., YÖNAL HİNDİLERDEN İ., Gültürk E., ERBİLGİN Y., et al.
49. Ulusal Hematoloji Kongresi, Antalya, Turkey, 01 November 2023, (Summary Text)
2023
20238. Insight into hypereosinophilia from the hematology clinic; A single-center experience
OLUK B., TAGHİYEVA N., SAKCI E., ERDEM S., YÖNAL HİNDİLERDEN İ., YENEREL M. N., et al.
Soho 2023 Türkiye Tenth Annual Meeting, İstanbul, Turkey, 05 May 2023, pp.64, (Summary Text)
2023
20239. A rare case of multiple myeloma presenting as a cranial nerve palsy
SAKCI E., YÖNAL HİNDİLERDEN İ., TİRYAKİ T. O., OLUK B., ÇATMA Y., ERDEM S., et al.
Soho 2023 Türkiye Tenth Annual Meeting, İstanbul, Turkey, 05 May 2023, pp.61, (Summary Text)
2023
202310. IMPACT OF EPITOPE MATCH ON STEM CELL TRANSPLANTATION
Öğret Y., Tiryaki T. O., Nasr Zanjani B., İzgi D., Çınar Ç., Yönal Hindilerden İ., et al.
Society of hematologic oncology, İstanbul, Turkey, 5 - 07 May 2023, pp.33, (Summary Text)
2022
202211. Büyük granüllü lenfosit artışı olan olguların tanısında immünfenotiplemenin rolü: Tek merkez deneyimi
NAZLIGÜL SERT E., TİRYAKİ T. O., ÖZBALAK M. M., MASTANZADE M., ÖZLÜK D. Ö., ERDEM S., et al.
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 01 November 2022, pp.199-200, (Summary Text)
2022
202212. Kronik lenfositer lösemi olgularının tanı sırasındaki T lenfosit alt gruplarının prognoz üzerine etkisi
SEYİTHANOĞLU D., NAZLIGÜL SERT E., ERDEM S., ÖZBALAK M. M., MASTANZADE M., ÖZLÜK D. Ö., et al.
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 01 November 2022, pp.145-146, (Summary Text)
2022
202213. An unusual ocular lymphoma, primary intravitreal lymphoma diagnosed incidentally
İBİLİ ÇETİNKAYA N. S., ERDEM S., DENİZ N., BAŞARIR B., ARTUNAY H. Ö., TİRYAKİ T. O., et al.
XIII Eurasian Hematology Oncology Congress EHOC 2022, İstanbul, Turkey, 05 October 2022, vol.44, pp.30-31, (Summary Text)
2022
202214. Hematopoetik Kök Hücre Nakli Sonrası BOS Kimerizm Analizi
Ögret Y., Tiryaki T. O., Çınar Ç., Yönal Hindilerden İ., Kubilay D. Ö., Nalçacı M., et al.
8. Ulusal Transplantasyon İmmunolojisi ve Genetiği Kongresi, Antalya, Turkey, 14 - 17 April 2022, pp.89-90, (Summary Text)
2022
202215. Epitop Uyumsuzluklarının Hematopoetik Kök Hücre Nakli Üzerine Etkisi
Ögret Y., Tiryaki T. O., Zanjani B. N., Kıvanç D., Çınar Ç., Yönal Hindilerden İ., et al.
8. Ulusal Transplantasyon İmmunolojisi ve Genetiği Kongresi, Antalya, Turkey, 14 - 17 April 2022, pp.88-89, (Summary Text)
2022
202216. Epitop Uyumsuzluklarının Hematopoetik Kök Hücre Nakli Üzerine Etkisi
Duvarcı Öğret Y., Tiryaki T. O., Nasr Zanjanı B., Kıvanç D., Çınar Ç., Yönal Hindilerden İ., et al.
8. ULUSAL TRANSPLANTASYON İMMÜNOLOJİSİ VE GENETİĞİ KONGRESİ, Antalya, Turkey, 14 - 17 April 2022, pp.88, (Summary Text)
2022
202217. Allogeneik Kök Hücre Nakli Hastalarında Erken Evre Doku Kimerizminin Periferik Kan Kimerizmi İle İlişkisi
Ögret Y., Pınar Özbalak E., Yönal Hindilerden İ., Beşışık S., Nalçacı M., Oğuz F.
8. Ulusal Transplantasyon İmmunolojisi ve Genetiği Kongresi, Antalya, Turkey, 14 - 17 April 2022, pp.31-32, (Summary Text)
2021
202118. TET2 gene variations in patients with myeloid malignancies
Aday A., Sırma Ekmekci S., Bayrak A. G., Çefle K., Öztürk Ş., Nalçacı M., et al.
XVII. Tıbbi Biyoloji ve Genetik Kongresi, 28 - 31 October 2021, vol.52, pp.242-243, (Summary Text)
2021
202119. WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?
ERDEM S., MASTANZADE M., ÖZBALAK M. M., KUBİLAY D. Ö., TİRYAKİ T. O., OLUK B., et al.
XIIth Eurasian Hematology-Oncology Congress, İSTANBUL (Hibrit Kongre), Turkey, 10 November 2021, vol.43, pp.96, (Summary Text)
2021
202120. OTOLOG HEMATOPOETİK KÖK HÜCRE NAKLİ SONRASINDAGÖRÜLEN NADİR KOMLİKASYON: AKUT GRAFT VERSUSHOST HASTALIĞI
Tiryaki T. O., Yönal Hindilerden İ., Kubilay D. Ö., Berker N., Büyük M., Nalçacı M.
47. Ulusal Hematoloji Kongresi, Antalya, Turkey, 4 - 07 November 2021, pp.322, (Summary Text)
2021
202121. Hematopoietik kök hücre transplant alıcılarında CMV enfeksiyonu ile bakteriyel ve fungal enfeksiyonlar arasındaki ilişkinin değerlendirilmesi
Öksüz L., Yönal Hindilerden İ., Erciyestepe M., Önel M., Hindilerden F., Çağatay A. A., et al.
6. Ulusal KLİMUD Kongresi, İstanbul, Turkey, 20 - 24 October 2021, pp.49, (Full Text)
2021
202122. Hematopoietik kök hücre transplant alıılarında CMV enfeksiyonu ile bakteriyel ve fungal enfeksiyonlar arasındaki ilişkinin değerlendirilmesi
ÖKSÜZ L., YÖNAL HİNDİLERDEN İ., ERCİYESTEPE M., ÖNEL M., HİNDİLERDEN F., ÇAĞATAY A. A., et al.
6. Ulusal KLİMUD Kongresi, İstanbul, Turkey, 20 October 2021, (Full Text)
2021
202123. Investigation Of Some Candidate Genes Determined From Multiple Myeloma Whole Genome Transcriptome Data
Sariman M., KARAÇAM B., Ayer M., SIRMA EKMEKCİ S., SUER İ., ÇEFLE K., et al.
EACR 2021 Virtual Congress-Innovative Cancer Science: Better Outcomes through Research, 9 - 12 June 2021, pp.1, (Summary Text)
2021
202124. CEBPA c.584_589dup p.His195Pro196dup variant in myeloid malignancies
SUER İ., SIRMA EKMEKCİ S., Aday A., Bayrak A. G., ÇEFLE K., ÖZTÜRK Ş., et al.
The Virtual Conference on Current Challenges in Hematology (C-HEM2021), İstanbul, Turkey, 18 - 19 March 2021, (Summary Text)
2021
202125. Investigation Of Possibly Related Genes Determined From Bioinformatic Analysis Of Multiple Myeloma Whole Genome Transcriptome Data
Sariman M., KARAÇAM B., AYER M., SIRMA EKMEKCİ S., SUER İ., ÇEFLE K., et al.
8th Multidisciplinary Cancer Research Congress, İstanbul, Turkey, 16 - 17 January 2021, pp.123, (Summary Text)
2020
202026. Prognostic value of pre-treatment neutrophil-lymphocyte and platelet-lymphocyte ratio in diffuse large B-cell lymphoma: a single-center experience
Dağcı G., Mastanzade M., Özbalak M. M., Kubilay D. Ö., Tiryaki T. O., Yönal Hindilerden İ., et al.
XIth Eurasian Hematology Oncology Congress, İstanbul, Turkey, 21 - 24 October 2020, no.42, pp.48-49, (Summary Text)
2020
202027. AKUT LÖSEMİ TANILI HASTALARDA TEDAVİ YANITININ VE SAĞKALIMIN DEĞERLENDİRİLMESİ
MEDETALİBEYOĞLU A., NALÇACI M.
22. ULUSAL İÇ HASTALIKLARI KONGRESİ, Turkey, 11 October 2020, (Summary Text)
2020
202028. Deterioration of endothelial function in mastocytosis patients with or without anaphylaxis
ÖZTOP N., Karaca O. P., DEMİR S., AYDOĞAN M., BEYAZ Ş., TİRYAKİ T. O., et al.
European-Academy-of-Allergology-and-Clinical-Immunology Digital Congress (EAACI), London, Canada, 6 - 08 June 2020, vol.75, pp.201-202, (Summary Text)
2020
202029. Poliklinik hastalarında teknolojik cihaz kullanımının ilaç kullanımı ile ilişkisi
Kahraman M., Karan M. A., Nalçacı M.
Geleneksel İç Hastalıkları Günleri - İnteraktif Güncelleştirme, Sakarya, Turkey, 12 - 15 March 2020, pp.95, (Summary Text)
2019
201930. LANGERHANS HÜCRELİ HİSTİYOSİTOZ: TEK MERKEZ DENEYİMİ
DEMİR N., TURAN ERKEK E., ERDEM S., NALÇACI M., BEŞIŞIK S.
45. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 01 November 2019, pp.155-156, (Summary Text)
2019
201931. Comparison of outcomes of total body irradiation (TBI) vs non-TBI conditioning regimens in acute lymphoblastic leukemia for allogeneic transplantation
Bekoz H. S., Sevindik O. G., Ozcelik T., Arat M., Hindilerden I. Y., Besisik S., et al.
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.217-218, (Summary Text)
2019
201932. A Case of a Variant Philadelphia Translocation Involving Chromosomes (7;9;22)(q22;q34;q11) in Chronic Myeloid Leukemia
BAYRAK A. G., ADAY A., UÇUR A., ÖZBALAK M. M., NALÇACI M., ÇEFLE K., et al.
13th Balkan Congress of Human Genetics, Edirne, Turkey, 17 - 20 April 2019, vol.BJMG, no.39, pp.76, (Summary Text)
2018
201833. The Importance of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria: A Cohort Study
Yenerel M. N., Erdem S., Mastanzade M., Nalcaci M.
60th Annual Meeting of the American-Society-of-Hematology (ASH), California, United States Of America, 1 - 04 December 2018, vol.132, (Summary Text)
2018
201834. Secondary primary malignancies after autologous hematopoietic stem cell transplantation: Single center experience
TEKİN D., DAĞCI G., YÖNAL HİNDİLERDEN İ., ERDEM S., AKTAN M., NALÇACI M., et al.
44th Annual Meeting of the European Society for Blood and Marrow Transplantation, Lisbon, Portugal, 18 March 2018, (Summary Text)
2018
201835. Akut Lenfoblastik Lösemi’de Hazırlama Rejimine Tüm Vücut Işınlaması Eklenmesinin Nakil İlişkili Sonlanımlara Etkisi
BEKÖZ H. S., SEVİNDİK Ö. G., ÖZÇELİK E. T., ARAT M., YÖNAL HİNDİLERDEN İ., BEŞIŞIK S., et al.
44. Ulusal Hematoloji Kongresi, Antalya, Turkey, 31 October 2018, (Full Text)
2018
201836. Infectious epidemiology in Multiple Myeloma patients after Autologous Stem Cell Transplantation: A single-center analysis from Turkey
Amikishiyev S., Hindilerden I. Y., Erdem S., Aktan M., Nalcaci M., Sargin D., et al.
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.566-567, (Summary Text)
2018
201837. Secondary primary malignancies after autologuous hematopoietic stem cell transplantation: Single center experience
Tekin D., Dagci G., Hindilerden I. Y., Erdem S., Aktan M., Nalcaci M., et al.
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.368-369, (Summary Text)
2018
201838. Akut Myeloid Lösemi ve 3q Kromozomal Yeniden Düzenlenmeleri
Bagatir G., Kaya M., Dön B., SUER İ., NALÇACI M., YENEREL M. N., et al.
3. Ulusal Uygulamalı Biyolojik Bilimler Kongresi (UBBK), Eskişehir, Turkey, 3 - 05 May 2018, vol.1, pp.35, (Summary Text)
2018
201839. Allojenik kemik İliği Nakli Yapılan Hastalarda Glutatyon S transferaz ve Sitokrom P450 Enzim Gen Polimorfizminin Klink Seyirle İlişkisi
Beşışık S., Yönal Hindilerden İ., Dağcı G., Nalçacı M., Bozbey H. U., Tekin D., et al.
V. Uluslararası Katılımlı Deneysel Hematoloji Kongresi, Malatya, Turkey, 27 - 29 April 2018, pp.1-3, (Summary Text)
2017
201740. Acute lung injury during mobilization of peripheral blood stem cells with granulocyte-colony stimulating factor
YÖNAL HİNDİLERDEN İ., ERDEM S., NİZAM N., ERELEL M., AKTAN M., NALÇACI M.
6th International Congress on Leukemia Lymphoma Myeloma, Antalya, Turkey, 11 May 2017, (Summary Text)
2016
201641. Lökositoz ile ortaya çıkan karaciğer tutulumlu nüks/dirençli saçlı hücreli lösemi olgusu
ERDEM S., GENÇ S., YÖNAL HİNDİLERDEN İ., DEMİR N., ÖZKAN S. G., ARSLAN Ö., et al.
42. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 19 October 2016, (Summary Text)
2016
201642. Lenalidomid ilişkili hipersensitivite reaksiyonlarında desensitizasyon deneyimi
DEMİR N., DEMİR S., ÖZKAN S. G., ERDEM S., ARSLAN Ö., NALÇACI M., et al.
42. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 19 October 2016, (Summary Text)
2016
201643. Splenik marjinal zon lenfomanın epidermotropik B hücreli lenfoma olarak ikincil prezentasyonu
ERDEM S., NALÇACI M., KILIÇ SAYAR S., BAYKAL C.
İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2016, Sapanca, Turkey, 11 March 2016, (Summary Text)
2015
201544. Circulating Endothelial Progenitor Cells and Their Relation to Thrombosis in Paroxysmal Nocturnal Hemoglobinuria
Erkek E. T., Nazligul E., Nalcaci M., Aktan M., Yenerel M. N.
57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 5 - 08 December 2015, vol.126, (Summary Text)
2015
201545. Langerhans dışı histiyositoz tanısıyla izlenirken granülositik sarkom gelişen olgu sunumu
ERDEM S., ÖZKAN S. G., YÖNAL HİNDİLERDEN İ., DOĞAN İ. Ö., NALÇACI M.
41. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 21 October 2015, (Summary Text)
2015
201546. Lenalidomide desensitization in two patients with two different reaction types
DEMİR S., OLGAÇ M., ÜNAL D., GELİNCİK A., ÇOLAKOĞLU B., BÜYÜKÖZTÜRK S., et al.
5th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Turkey, 21 - 23 May 2015, pp.140, (Full Text)
2013
201347. Prognostic Significance Of ASXL1 and IDH Mutations in Philadelphia Negative Myeloproliferative Neoplasms
YÖNAL İ., ADAY A., AKADAM-TEKER B., YILMAZ C., NALÇACI M., YAVUZ A. S., et al.
55th ASH Annual Meeting, New Orleans, La, United States Of America, 7 - 10 December 2013, vol.122, no.21, (Summary Text)
2013
201348. Esansiyel Trombositemi ve Primer Miyelofibrozis olgularında ASXL1, IDH1, IDH2 gen mutasyonları ve JAK2V617F allel yükü ile klinik seyir arasındaki ilişki
YÖNAL İ., ADAY A., TEKER A. B. A., YILMAZ C., NALÇACI M., YAVUZ A. S., et al.
39. Ulusal Hematoloji Kongresi, Antalya, Turkey, 23 - 26 October 2013, pp.53-55, (Full Text)
2013
201349. Elevated Thymidine Kinase Levels (TKI)may identify patients at high risk of disease progression in newly diagnosed multiple myeloma.
ELVERDİ T., TEMURHAN S., OSMANBAŞOĞLU E., AKGÜL S., AYDIN F., NALÇACI M., et al.
4 th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Turkey, 22 - 25 May 2013, pp.310-311, (Full Text)
2013
201350. Detection of Myc Gene Rearrangements by Fluorescence In Situ Hybridization In Acute Lymphpoblastic Leukemia Cases.
Eren S., ÇIRAKOĞLU A., KURU R. D., BAŞLAR Z., Devecioğlu Ö., Nalçacı M., et al.
4 th International Congress on Leukemia-Lymphoma-Myeloma, Turkey, 1 - 04 May 2013, pp.283, (Full Text)
2012
201251. Can Activation Induced Cytidine Deaminase Lead to Genetic Instability in Bcr-Abl Negative Myeloproliferative Neoplasms?
Dermenci H., Daglar A., Akadam B. P., Hancer V. S., Gelmez Y., Aktan M., et al.
54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 8 - 11 December 2012, vol.120, (Summary Text)
2010
201052. Frequency and clinical outcomes of platelet membrane glycoprotein polymorphisms in antiphospholipid syndrome
Yonal I., Hindilerden F., Hancer V. S., Esen B. A., Nalcaci M., Kucukkaya R. D.
52nd Annual Meeting of the American-Society-of-Hematology (ASH), Florida, United States Of America, 4 - 07 December 2010, vol.116, pp.1303-1304, (Summary Text)
2009
200953. İstanbul Tıp Fakültesi Kemik İliği Bankası (İTF KİBANK).
OĞUZ F., ÇINAR Ç., KARAHAN G. E., TEMURHAN S., ÖGRET Y., BEŞIŞIK S., et al.
35. Ulusal Hematoloji Kongresi, Antalya, Turkey, 7 - 10 October 2009, pp.1-2, (Full Text)
2006
200654. Does previous interferon use have negative effect on imatinib response in chronic myeloid leukemia (CML)? A single center study.
Yenerel M. N., Diz-Kucukkaya R., Demirel N., Ayer M., Yavuz S., Besisik S., et al.
48th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 9 - 12 December 2006, vol.108, (Summary Text)
Books
2023
20231. Erişkin Yaşamda Hemoglobinopatili Hasta İzlem ve Tedavisi
ERDEM S., NALÇACI M.
in: KALITSAL HEMOLİTİK ANEMİLER, Prof. Dr. Zeynep KARAKAŞ, Editor, Türkiye Klinikleri, Ankara, pp.94-100, 2023
Other Publications
2020
20201. A Case with Hepatic Involvement Mimicking Metastatic Disease in Multiple Myeloma
Tiryaki T. O., Yönal Hindilerden İ., Nalçacı M., Yegen G., Erciyestepe M.
Other, pp.1-4, 2020
Funded Projects
2023 - 2025
2023 - 2025Akut Miyeloid Lösemi ve Miyelodisplastik Sendromlu Hastalarda TET2 Gen Varyantlarının Araştırılması
Project Supported by Higher Education Institutions , BAP Research Project
ADAY A. (Executive), BAYRAK A. G., PALANDUZ Ş., ERDEM S., ÇEFLE K., ÖZTÜRK Ş., et al.
2016 - 2018
2016 - 2018Myelodisplastik Sendromlu Hastalarda Aktivasyonla İndüklenen Sitidin Deaminazın Ekspresyon Düzeyinin ve Prognozla İlişkisinin Değerlendirilmesi
Project Supported by Higher Education Institutions , BAP PhD
NALÇACI M. (Executive), ADAY A., TORUN E. S.
2009 - 2012
2009 - 2012MYELOPROLİFERATİF HASTALIKLARDA MPL GEN MUTASYON SIKLIĞI VE TROMBOZ İLE İLİŞKİSİ
Project Supported by Higher Education Institutions , BAP PhD
NALÇACI M. (Executive)
2010 - 2011
2010 - 2011Antifosfolipid Sendromunda beta 2 glikoprotein I Valin/Lösin 247 polimorfizminin önemi
Project Supported by Higher Education Institutions , BAP PhD
NALÇACI M. (Executive)
2009 - 2011
2009 - 2011İmmün Trombositopenik Purpuralı Hastalarda Retiküle Trombosit Sayısının Tedavi Cevabı İle İlişkisi
Project Supported by Higher Education Institutions , BAP PhD
NALÇACI M. (Executive)
2009 - 2010
2009 - 2010Primer antifosfolipid sendromunda (PAPS) trombosit membran glikoprotein polimorfizmlerin klinik ve fonksiyonel sonuçları
Project Supported by Higher Education Institutions , BAP PhD
NALÇACI M. (Executive), YÖNAL İ.